AIM ImmunoTech Inc.
AIM- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000946644
In the last 90 days, AIM ImmunoTech Inc. insiders filed 4 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $325.6K in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in AIM ImmunoTech Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- +1 vs. Q1 2021
- Shares held
- 7.21M
- −215.9K (−2.9%) vs. Q1 2021
- Total value
- $15.5M
- −$1.36M (−8.1%) vs. Q1 2021
- New holders
- 10
- 9 more added
- Sold out
- 9
- 5 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AIM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 18 | $325.6K |
| Q1 2026 | 18 | $102.8K |
| Q4 2025 | 13 | $119.8K |
| Q3 2025 | 15 | $293.9K |
| Q2 2025 | 12 | $104.8K |
| Q1 2025 | 34 | $590.0K |
| Q4 2024 | 35 | $919.3K |
| Q3 2024 | 33 | $2.43M |
| Q2 2024 | 36 | $3.15M |
| Q1 2024 | 33 | $1.93M |
| Q4 2023 | 38 | $1.83M |
| Q3 2023 | 38 | $1.97M |
| Q2 2023 | 34 | $3.01M |
| Q1 2023 | 36 | $2.05M |
| Q4 2022 | 39 | $1.67M |
| Q3 2022 | 38 | $3.36M |
| Q2 2022 | 40 | $4.68M |
| Q1 2022 | 38 | $7.12M |
| Q4 2021 | 43 | $6.86M |
| Q3 2021 | 38 | $14.7M |
| Q2 2021 | 39 | $15.5M |
| Q1 2021 | 38 | $16.8M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding AIM ImmunoTech Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 2,507,390 | $5.39M | 0.00% | +1,436+0.1% | Added |
| Vanguard Group Inc | 1,993,156 | $4.29M | 0.00% | +66,757+3.5% | Added |
| BlackRock Inc. | 822,690 | $1.77M | 0.00% | −156,352−16.0% | Reduced |
| Geode Capital Management, LLC | 351,750 | $756.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 246,000 | $529.0K | 0.01% | −25,000−9.2% | Reduced |
| State Street Corp | 160,413 | $345.0K | 0.00% | +160,413 | New |
| Renaissance Technologies LLC | 152,848 | $329.0K | 0.00% | −325,911−68.1% | Reduced |
| Dimensional Fund Advisors LP | 139,160 | $299.0K | 0.00% | +139,160 | New |
| Price T Rowe Associates Inc | 116,800 | $251.0K | 0.00% | 00.0% | Unchanged |
| Verition Fund Management LLC | 108,000 | $232.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 87,226 | $188.0K | 0.00% | +19,480+28.8% | Added |
| HighTower Advisors, LLC | 67,171 | $144.0K | 0.00% | +4,076+6.5% | Added |
| Winton Group Ltd | 54,894 | $118.0K | 0.01% | +54,894 | New |
| Raymond James Financial Services Advisors, Inc. | 47,950 | $103.0K | 0.00% | +47,950 | New |
| Cambridge Investment Research Advisors, Inc. | 46,679 | $100.0K | 0.00% | 00.0% | Unchanged |
| SeaCrest Wealth Management, LLC | 43,563 | $94.0K | 0.01% | 00.0% | Unchanged |
| Rockefeller Capital Management L.P. | 40,000 | $86.0K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 29,269 | $63.0K | 0.02% | +29,269 | New |
| Bank of New York Mellon Corp | 25,268 | $54.0K | 0.00% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 23,100 | $49.0K | 0.00% | −15,400−40.0% | Reduced |
| Charles Schwab Investment Management Inc | 20,316 | $44.0K | 0.00% | 00.0% | Unchanged |
| Captrust Financial Advisors | 20,000 | $43.0K | 0.00% | +6,000+42.9% | Added |
| LPL Financial LLC | 17,025 | $37.0K | 0.00% | +525+3.2% | Added |
| Bank of America Corp | 15,023 | $32.0K | 0.00% | −61−0.4% | Reduced |
| Community Bank, N.A. | 13,226 | $28.0K | 0.00% | 00.0% | Unchanged |
| Traynor Capital Management, Inc. | 11,777 | $24.0K | 0.00% | 00.0% | Unchanged |
| Lehman & Derafelo Financial Resources LLC | 11,100 | $24.0K | 0.01% | 00.0% | Unchanged |
| Wells Fargo & Company | 10,809 | $23.0K | 0.00% | +7,044+187.1% | Added |
| SNS Financial Group, LLC | 10,000 | $22.0K | 0.00% | +10,000 | New |
| Tower Research Capital LLC (TRC) | 9,733 | $21.0K | 0.00% | +9,733 | New |
| JPMorgan Chase & Co | 2,399 | $5.00K | 0.00% | +2,397+119,850.0% | Added |
| Advisor Group Holdings, Inc. | 855 | $2.00K | 0.00% | +399+87.5% | Added |
| Proequities, Inc. | 500 | $1.00K | 0.00% | +500 | New |
| American Portfolios Advisors | 228 | $490 | 0.00% | 00.0% | Unchanged |
| Huntington National Bank | 57 | $0 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 17 | $0 | 0.00% | 00.0% | Unchanged |
| Jacobi Capital Management LLC | 2 | $0 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 1 | $0 | 0.00% | +1 | New |
| Royal Bank of Canada | 14 | $0 | 0.00% | +14 | New |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −103,283−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −74,790−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −29,484−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −17,900−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −17,000−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Global Wealth Management Investment Advisory, Inc. | 0 | $0 | 0.00% | −600−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −120−100.0% | Sold out |